to Assess the Safety of Ga68-Dolacga Injection in Healthy Volunteers
NCT03908957
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
12
Enrollment
OTHER
Sponsor class
Conditions
Safety Issues
Interventions
DRUG:
Ga68-Dolacga Injection
Sponsor
National Atomic Research Institute, Taiwan